Skip to main content

Telomir Pharmaceuticals, Inc.

TELO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001971532

No open-market purchases or sales by Telomir Pharmaceuticals, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $3.80M in total; no superinvestor holds it.

Members of Congress who traded TELO

No member of Congress has reported a trade in Telomir Pharmaceuticals, Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.